← Back to Clinical Trials
Recruiting NCT04650607

Phage Safety Cohort Study

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Prosthetic Joint Infection
Sponsor Hospices Civils de Lyon
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2022-05-09
Completion 2023-10-09
Interventions
Adverse event after injection of phages

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This cohort study aims to describe the adverse events related to the use of bacteriophages to treat serious infections, data from the literature being almost non-existent on this subject.

Eligibility Criteria

Inclusion Criteria: * Patient 18 years of age or older with a serious infection treated at CRIOAc Lyon by phage therapy * Patient who did not object to participating in the study * Patients ayant un poids minimum de 46kg Exclusion Criteria: * Patients under guardianship/curatorship * Patients deprived of liberty * Pregnant or breastfeeding women

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}